Literature DB >> 7393813

Cholestatic jaundice due to co-trimoxazole.

A L Ogilvie, P J Toghill.   

Abstract

A patient developed cholestatic jaundice following therapy with co-trimoxazole. Inadvertent re-challenge with the drug resulted in further clinical and biochemical deterioration, but complete recovery ensued on stopping this drug.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7393813      PMCID： PMC2425863          DOI： 10.1136/pgmj.56.653.202

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  7 in total

1.  Letter: Hepatic necrosis and trimethoprim-sulfamethoxazole.

Authors:  C F Colucci; M Lo Cicero
Journal:  JAMA       Date:  1975-09-01       Impact factor: 56.272

2.  [Liver changes after sulfamethoxazole-trimethoprim (Bactrim, Trisural)].

Authors:  K Hermansen; P Baunsgaard; G Heydenreich; G Nielsen
Journal:  Ugeskr Laeger       Date:  1976-02-09

3.  Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole.

Authors:  C A Dujovne; C H Chan; H J Zimmerman
Journal:  N Engl J Med       Date:  1967-10-12       Impact factor: 91.245

4.  Hepatitis attributed to sulfamethoxazole.

Authors:  K L Macoul
Journal:  N Engl J Med       Date:  1966-07-07       Impact factor: 91.245

5.  Methyldopa-induced submassive hepatic necrosis.

Authors:  O U Rehman; T A Keith; E A Gall
Journal:  JAMA       Date:  1973-06-04       Impact factor: 56.272

6.  Simultaneous occurrence of toxic hepatitis and Stevens-Johnson syndrome following therapy with sulfisoxazole and sulfamethoxazole.

Authors:  D J Shaw; R P Jacobs
Journal:  Johns Hopkins Med J       Date:  1970-03

7.  Sulfonamide hepatitis. Report of a case due to sulfamethoxazole and sulfisoxazole.

Authors:  J Fries; R Siragenian
Journal:  N Engl J Med       Date:  1966-01-13       Impact factor: 91.245
  7 in total
  3 in total

1.  Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone.

Authors:  Pradeep Reddy Kathi; Maher Tama; Murray Ehrinpreis; Milton Mutchnick; Maria Westerhoff; Jonathan Mowers; Robert John Fontana
Journal:  Clin J Gastroenterol       Date:  2019-07-17

Review 2.  Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature.

Authors:  David A Barr; Pravistadevi K Ramdial
Journal:  BMC Infect Dis       Date:  2012-10-14       Impact factor: 3.090

Review 3.  Severe and prolonged cholestasis caused by trimethoprim-sulfamethoxazole: a case report.

Authors:  Luciana C Faria; Clarissa C Resende; Cláudia A Couto; Osvaldo F M Couto; Lúcia P C Fonseca; Teresa Cristina A Ferrari
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.